No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs550630219 |
chr14:65735313-65735314 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs529999548 |
chr14:65735342-65735343 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs1256515 |
chr14:65735357-65735358 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
4 |
rs570134951 |
chr14:65735376-65735377 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs539111754 |
chr14:65735430-65735431 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs77668270 |
chr14:65735432-65735433 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs2151756 |
chr14:65735437-65735438 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs565870716 |
chr14:65735493-65735494 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs534865551 |
chr14:65735494-65735495 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs554520886 |
chr14:65735498-65735499 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs137877719 |
chr14:65735503-65735504 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs543018458 |
chr14:65735507-65735508 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs367883036 |
chr14:65735524-65735525 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs1256516 |
chr14:65735539-65735540 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs576459289 |
chr14:65735568-65735569 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs539058904 |
chr14:65735610-65735611 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs78888170 |
chr14:65735625-65735626 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive regionlncRNA
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs1256517 |
chr14:65735684-65735685 |
Enhancers Weak transcription
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
19 |
rs541619654 |
chr14:65735754-65735755 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs199884789 |
chr14:65735783-65735784 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs372690938 |
chr14:65735799-65735800 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs561386520 |
chr14:65735804-65735805 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs34941420 |
chr14:65735811-65735812 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs79607886 |
chr14:65735823-65735824 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs202039432 |
chr14:65735825-65735826 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs530443053 |
chr14:65735834-65735835 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs550521360 |
chr14:65735839-65735840 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs374143102 |
chr14:65735869-65735870 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs141644999 |
chr14:65735900-65735901 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs1256518 |
chr14:65735932-65735933 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs562568316 |
chr14:65735970-65735971 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs192618785 |
chr14:65735987-65735988 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs367680037 |
chr14:65736034-65736035 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs534478037 |
chr14:65736052-65736053 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs542117468 |
chr14:65736078-65736079 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs183948274 |
chr14:65736088-65736089 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs187583825 |
chr14:65736089-65736090 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs78924904 |
chr14:65736118-65736119 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs150479225 |
chr14:65736156-65736157 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs192118278 |
chr14:65736163-65736164 |
Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs1038237 |
chr14:65736178-65736179 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs1038238 |
chr14:65736182-65736183 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs373198928 |
chr14:65736237-65736238 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs541246529 |
chr14:65736259-65736260 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs561507030 |
chr14:65736269-65736270 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs531167033 |
chr14:65736299-65736300 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs1256519 |
chr14:65736324-65736325 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs115141331 |
chr14:65736348-65736349 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs371675354 |
chr14:65736352-65736353 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs563974531 |
chr14:65736375-65736376 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|